Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hematologic Neoplasms 4Glioma 3Multiple Myeloma 2Breast Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Smoking Cessation 1Sarcoma 1Osteosarcoma 1Neoplasms 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Medulloblastoma 1Lung Neoplasms 1Hypogonadism 1Hematopoietic and Lymphatic System Neoplasm 1Heart Failure 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Colonic Neoplasms 1Colitis 1Central Nervous System Neoplasms 1Cardiomyopathies 1Carcinoma, Non-Small-Cell Lung 1Anemia, Aplastic 1

Interventions

trifluridine tipiracil drug combination 1testosterone 17 beta-cypionate 1atezolizumab 1Testosterone Propionate 1Sunitinib 1Standard of Care 1Practice Guidelines as Topic 1Methyltestosterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Urologic Diseases × Standard of Care × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡